Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tempest Therapeutics, Inc.TPST · Entity 7734 | Director | September 22, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tempest Therapeutics, Inc.
Report date September 22, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2036-09-22 | Direct | 25,000 |
Reported balance
After 2026-09-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-22 · Grant · Acquired 25,000 · Balance 25,000 F1: The shares subject to each such stock option will vest over a three-year period, with one-third of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to each such stock option will vest over a three-year period, with one-third of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CHUY'S HOLDINGS, INC.
Report date October 11, 2024 · Filed October 15, 2024
Section 16 reporting ended · disclosed 2024-10-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-10-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-11 · Disposition to issuer · Disposed 1,084 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement," and the transactions contemplated by the Merger Agreement, the "Merger") by and among Darden Restaurants, Inc. ("Darden"), Cheetah Merger Sub Inc. and Chuy's Holdings, Inc. (the "Company"), immediately prior to the Effective Time (as defined in the Merger Agreement), by virtue of the Merger and without any action on the part of the holder, each restricted stock unit (each, an "RSU") then outstanding was deemed to have been earned, and became fully vested and was canceled in exchange for the right to receive from Darden or the surviving corporation an amount in cash equal to the product obtained by multiplying (1) the number of shares of the Company's common stock subject to such RSU by (2) $37.50. F2: The RSUs were granted on May 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement," and the transactions contemplated by the Merger Agreement, the "Merger") by and among Darden Restaurants, Inc. ("Darden"), Cheetah Merger Sub Inc. and Chuy's Holdings, Inc. (the "Company"), immediately prior to the Effective Time (as defined in the Merger Agreement), by virtue of the Merger and without any action on the part of the holder, each restricted stock unit (each, an "RSU") then outstanding was deemed to have been earned, and became fully vested and was canceled in exchange for the right to receive from Darden or the surviving corporation an amount in cash equal to the product obtained by multiplying (1) the number of shares of the Company's common stock subject to such RSU by (2) $37.50.
F2: The RSUs were granted on May 15, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2026 Filed Oct 3, 2026 00:18 UTC | Tempest Therapeutics, Inc. TPST · Entity 7734 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001213900-26-106400 · ownership.xml · derivative · entry 1 Smith Nancy Freda · CIK 0002019811 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-09-22 F1 · derivative.exercise_date: The shares subject to each such stock option will vest over a three-year period, with one-third of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 16:04 UTC | CHUY'S HOLDINGS, INC. CHUY · Entity 86768 | Disposition to issuerRestricted Stock Units · Derivative | 1,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001524931-24-000126 · wk-form4_1729022673.xml · derivative · entry 1 Smith Nancy Freda · CIK 0002019811 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,084 shares Expires not disclosed F1 · derivative.exercise_price: Pursuant to that certain Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement," and the transactions contemplated by the Merger Agreement, the "Merger") by and among Darden Restaurants, Inc. ("Darden"), Cheetah Merger Sub Inc. and Chuy's Holdings, Inc. (the "Company"), immediately prior to the Effective Time (as defined in the Merger Agreement), by virtue of the Merger and without any action on the part of the holder, each restricted stock unit (each, an "RSU") then outstanding was deemed to have been earned, and became fully vested and was canceled in exchange for the right to receive from Darden or the surviving corporation an amount in cash equal to the product obtained by multiplying (1) the number of shares of the Company's common stock subject to such RSU by (2) $37.50. F2 · shares: The RSUs were granted on May 15, 2024. F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement," and the transactions contemplated by the Merger Agreement, the "Merger") by and among Darden Restaurants, Inc. ("Darden"), Cheetah Merger Sub Inc. and Chuy's Holdings, Inc. (the "Company"), immediately prior to the Effective Time (as defined in the Merger Agreement), by virtue of the Merger and without any action on the part of the holder, each restricted stock unit (each, an "RSU") then outstanding was deemed to have been earned, and became fully vested and was canceled in exchange for the right to receive from Darden or the surviving corporation an amount in cash equal to the product obtained by multiplying (1) the number of shares of the Company's common stock subject to such RSU by (2) $37.50. F1 · derivative.exercise_date: Pursuant to that certain Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement," and the transactions contemplated by the Merger Agreement, the "Merger") by and among Darden Restaurants, Inc. ("Darden"), Cheetah Merger Sub Inc. and Chuy's Holdings, Inc. (the "Company"), immediately prior to the Effective Time (as defined in the Merger Agreement), by virtue of the Merger and without any action on the part of the holder, each restricted stock unit (each, an "RSU") then outstanding was deemed to have been earned, and became fully vested and was canceled in exchange for the right to receive from Darden or the surviving corporation an amount in cash equal to the product obtained by multiplying (1) the number of shares of the Company's common stock subject to such RSU by (2) $37.50. F1 · derivative.expiration_date: Pursuant to that certain Agreement and Plan of Merger, dated as of July 17, 2024 (the "Merger Agreement," and the transactions contemplated by the Merger Agreement, the "Merger") by and among Darden Restaurants, Inc. ("Darden"), Cheetah Merger Sub Inc. and Chuy's Holdings, Inc. (the "Company"), immediately prior to the Effective Time (as defined in the Merger Agreement), by virtue of the Merger and without any action on the part of the holder, each restricted stock unit (each, an "RSU") then outstanding was deemed to have been earned, and became fully vested and was canceled in exchange for the right to receive from Darden or the surviving corporation an amount in cash equal to the product obtained by multiplying (1) the number of shares of the Company's common stock subject to such RSU by (2) $37.50. F2 · derivative.underlying_shares: The RSUs were granted on May 15, 2024. Read SEC document |
| May 15, 2024 Filed May 17, 2024 16:01 UTC | CHUY'S HOLDINGS, INC. CHUY · Entity 86768 | GrantRestricted Stock Units · Derivative | 1,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001524931-24-000065 · wk-form4_1715976042.xml · derivative · entry 1 Smith Nancy Freda · CIK 0002019811 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,084 Underlying: Common Stock · 1,084 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vest in four equal annual installments with the first annual installment vesting on May 15, 2025. Settlement will occur no later than 30 days after such date, subject to certain exceptions in the Restricted Stock Unit Agreement between the Issuer and the reporting person. F2 · derivative.expiration_date: These restricted stock units vest in four equal annual installments with the first annual installment vesting on May 15, 2025. Settlement will occur no later than 30 days after such date, subject to certain exceptions in the Restricted Stock Unit Agreement between the Issuer and the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.